Dasatinib, sold under the brand name Sprycel among others, is a targeted therapy medication used to treat certain cases of chronic myelogenous leukemia and acute lymphoblastic leukemia. From Wikipedia
The pharmaceutical company forecasts lower-than-expected earnings and revenue as it faces generic competition for key cancer drugs.
